Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Liabilities and Shareholders Equity: 2012-2025

Historic Liabilities and Shareholders Equity for CorMedix (CRMD) over the last 11 years, with Sep 2025 value amounting to $750.9 million.

  • CorMedix's Liabilities and Shareholders Equity rose 867.78% to $750.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 331.49%. This contributed to the annual value of $118.8 million for FY2024, which is N/A change from last year.
  • Per CorMedix's latest filing, its Liabilities and Shareholders Equity stood at $750.9 million for Q3 2025, which was up 197.25% from $252.6 million recorded in Q2 2025.
  • In the past 5 years, CorMedix's Liabilities and Shareholders Equity ranged from a high of $750.9 million in Q3 2025 and a low of $57.0 million during Q2 2023.
  • For the 3-year period, CorMedix's Liabilities and Shareholders Equity averaged around $168.3 million, with its median value being $84.5 million (2023).
  • Per our database at Business Quant, CorMedix's Liabilities and Shareholders Equity dropped by 22.94% in 2022 and then soared by 867.78% in 2025.
  • Over the past 5 years, CorMedix's Liabilities and Shareholders Equity (Quarterly) stood at $68.9 million in 2021, then dropped by 10.02% to $62.0 million in 2022, then soared by 47.28% to $91.4 million in 2023, then fell by 15.14% to $118.8 million in 2024, then skyrocketed by 867.78% to $750.9 million in 2025.
  • Its Liabilities and Shareholders Equity was $750.9 million in Q3 2025, compared to $252.6 million in Q2 2025 and $149.6 million in Q1 2025.